vigabatrin has been researched along with Color Vision Defects in 3 studies
Color Vision Defects: Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both examined antiepileptic drugs, vigabatrin and carbamazepine, cause acquired color vision defects." | 9.09 | Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. ( Kälviäinen, R; Mäntyjärvi, M; Nousiainen, I, 2000) |
| "Both examined antiepileptic drugs, vigabatrin and carbamazepine, cause acquired color vision defects." | 5.09 | Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. ( Kälviäinen, R; Mäntyjärvi, M; Nousiainen, I, 2000) |
| "21 consecutive patients who had taken vigabatrin at some time in their lives were enrolled from the epilepsy clinic of the Royal Shrewsbury Hospital and were compared with a group of 11 otherwise similar patients with epilepsy who had never received vigabatrin." | 3.70 | A controlled study of vigabatrin and visual abnormalities. ( Goodman, S; Manuchehri, K; Nightingale, S; Siviter, L, 2000) |
| "Vigabatrin (VGB) has been shown to cause visual field constriction and other forms of mild visual dysfunction." | 2.70 | Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. ( Johnson, MA; Krauss, GL; Medura, MT; Miller, NR; Miller, TA; Paul, SR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manuchehri, K | 1 |
| Goodman, S | 1 |
| Siviter, L | 1 |
| Nightingale, S | 1 |
| Nousiainen, I | 1 |
| Kälviäinen, R | 1 |
| Mäntyjärvi, M | 1 |
| Paul, SR | 1 |
| Krauss, GL | 1 |
| Miller, NR | 1 |
| Medura, MT | 1 |
| Miller, TA | 1 |
| Johnson, MA | 1 |
2 trials available for vigabatrin and Color Vision Defects
| Article | Year |
|---|---|
Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Color Perception; Color Perception Tests; Color Vision | 2000 |
Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making.
Topics: Adult; Aged; Anticonvulsants; Color Vision Defects; Drug Administration Schedule; Epilepsy; Female; | 2001 |
1 other study available for vigabatrin and Color Vision Defects
| Article | Year |
|---|---|
A controlled study of vigabatrin and visual abnormalities.
Topics: Adult; Aged; Anticonvulsants; Case-Control Studies; Color Vision Defects; Dose-Response Relationship | 2000 |